Last Price
40.00
Today's Change
+0.34 (0.85%)
Day's Change
39.40 - 43.24
Trading Volume
179,123
Market Cap
519 Million
Shares Outstanding
12 Million
Avg Volume
172,992
Avg Price (50 Days)
47.01
Avg Price (200 Days)
39.04
PE Ratio
-10.90
EPS
-3.67
Earnings Announcement
14-Nov-2024
Previous Close
39.66
Open
39.50
Day's Range
39.4 - 43.24
Year Range
12.49 - 74.49
Trading Volume
179,392
1 Day Change
0.86%
5 Day Change
-42.68%
1 Month Change
-19.60%
3 Month Change
19.15%
6 Month Change
26.78%
Ytd Change
101.31%
1 Year Change
185.71%
3 Year Change
-68.10%
5 Year Change
-28.83%
10 Year Change
-72.30%
Max Change
-83.26%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases. Its product candidate includes NGN-401, an investigational AAV9 gene therapy for the treatment of Rett syndrome; and NGN-101 to treat neuronal ceroid lipofuscinosis subtype 5 batten disease. The company is headquartered in New York, New York.